Shrink Nanotechnologies’ Biotech R&D Group Files Key Patent on StemDisc(TM) Biomedical Research Tool

CARLSBAD, Calif.--(BUSINESS WIRE)--Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB:INKN), an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications for its stem cell research and drug discovery tool StemDisc™ have been filed.
MORE ON THIS TOPIC